Chlorophyllin for brain radiation damage in glioma patients
Part of Cancer clinical trials.
This trial tests if chlorophyllin can help manage brain damage caused by radiation therapy in people with diffuse glioma. It may reduce symptoms or prevent them from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of brain tumor called diffuse glioma.
- You have brain damage from radiation (radionecrosis) seen on scans, with or without new or worsening symptoms.
- You are able to take care of most daily activities (Karnofsky score of 50 or higher).
- You have not had treatment with the drug bevacizumab before.
- You do not have a brainstem glioma or unclear signs of tumor progression versus radiation damage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans and related brain/cognitive testing while you receive standard chemotherapy and radiation for a high-grade brain tumor. It aims to see how MRI measures and brain testing may relate to your treatment response or brain function.
This trial tests a drug called Avastin (bevacizumab) for people with brain swelling (radionecrosis) after radiation. It's for those whose symptoms don't get better with steroids or come back when steroids are reduced.
This trial tests whether adding the drug ruxolitinib to standard radiation and chemotherapy (temozolomide) helps people with a newly diagnosed brain tumor called glioblastoma. It aims to see if the combination keeps the tumor from growing longer than the standard treatment alone.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This trial tests a precise type of radiation called carbon ion radiotherapy for people with aggressive brain tumors (high-grade gliomas). It aims to see if this treatment is safe and effective for patients who have not had radiation to the head before.
This trial tests a new oral drug called XRD-0394 given together with radiation therapy for people with high-grade glioma, a type of aggressive brain tumor. The goal is to see if adding this drug makes radiation more effective.
Hear when a new Diffuse Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.